The Canadian COVID‑19 Funded Research Database

Back to main page

Displaying 241 through 250 of 424 results (Download Results)

Show results per page

COVID-19 Variant Supplement – Towards anti-COVID-19 therapeutic development by targeting the viral papain-like proteinase

James, Michael N | University of Alberta | Operating Grant | $50,000

CIHR Alberta 2021

Social polarization and behavioral intentions during the COVID‑19 pandemic: A multi-site study of risk and protective factors in Canadian youth

Rousseau, Cecile | McGill University | Project Grant | $240,975

CIHR Quebec 2021

Defining the impact of pre-existing host immunity on SARS-CoV-2 incidence and COVID‑19 clinical outcome

Kaul, Rupert | University of Toronto | Project Grant | $489,600

CIHR Ontario 2021

COVID-19 Variant Supplement – Contribution of genetic variation of ACE2, the receptor for SARS-CoV-2, to COVID‑19 disease expression and development of therapeutics

Haas, Kurt | University of British Columbia | Operating Grant | $50,000

CIHR British Columbia 2021

Impact of Frailty and Sarcopenia on Post-COVID Recovery

Afilalo, Jonathan | CIUSSS de Centre-Ouest-de-l'Ile-de-Montréal-Jewish General | Operating Grant | $470,179

CIHR Quebec 2021

Comparative analyses of how SARS-CoV-2 variants of concern affect the host response in cells of the respiratory tract

Hobman, Tom C | University of Alberta | Operating Grant | $499,130

CIHR Alberta 2021

Developing and evaluating an online intervention to improve the uptake and maintenance of protective behaviours against COVID‑19 among young adults in Canada

Campbell, Tavis S | The University of Calgary | Project Grant | $271,575

CIHR Alberta 2021

COVID-19 Variant Supplement – The COVID‑19 Pandemic Among Sexual and Gender Marginalized Populations in Canada: Physical Distancing Impacts, SARS-CoV-2 Seroprevalence, and Health and Wellness Needs

Lachowsky, Nathan J | University of Victoria | Operating Grant | $50,000

CIHR British Columbia 2021

COVID-19 Variant Network – Development of SARS-CoV-2 Peptide Therapeutics and Point-of-Care Salivary Diagnostics for Rapid Viral Detection

Babu, Mohan | The University of Regina | Operating Grant | $100,000

CIHR Saskatchewan 2021

COVID-19 Variant Supplement – The role of interleukin-10 responsiveness in lung inflammation in SARS CoV2 infection

Mui, Alice L | University of British Columbia | Operating Grant | $50,000

CIHR British Columbia 2021

Please complete this short survey to help us understand our impact. Thank you!

Give Feedback